Broad clinician network MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients, indicating a large, established provider network ripe for upsell of additional testing panels and integrated diagnostic services.

CAP/CLIA credentials As a CAP-accredited and CLIA-licensed laboratory, MicroGenDX demonstrates compliance and quality, easing procurement for hospitals and health systems seeking certified partners for molecular infectious disease testing.

NGS qPCR leadership With NGS-enabled infectious disease testing and rapid results, there is a strong opportunity to position expanded panels (respiratory, wound, urinary infections) to hospitals and long-term care facilities aiming to shorten diagnostic timelines.

Strategic partnerships Past collaborations with Evvy, NASA, CDC, FDA, Mayo Clinic, and others suggest a track record of scalable partnerships; target health networks and research institutions seeking validated molecular diagnostics collaborations.

Recent expansions Recent launches such as Rapid H5 and patient-focused website indicate growth and consumer-facing accessibility; pursue direct-to-consumer clinics, telemedicine partners, and rural or urgent-care networks needing accessible, accurate microbial testing.